Structure Therapeutics(us:GPCR)
17.31
-12.44%
Updated on 2025-03-31
Open:19.13
Close:17.31
High:19.13
Low:17.25
Prev Close:19.77
Volume:1.21M
Turnover:21.38M
Turnover Ratio:2.11%
Shares:57.34M
MarketCap:992.60M
About Structure Therapeutics
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.
Company Name: Structure Therapeutics
Address: 601 Gateway Boulevard,Suite 900
Employees: 93
Fiscar Year: 12-31
IPO Date: 2023-02-03
Website: http://www.structuretx.com
CIK: 1888886
View all SEC Filings
About
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.
Address:601 Gateway Boulevard,Suite 900
Website:http://www.structuretx.com
Market Movers